Delivery Order SPE2DB25D9337-SPE2DB25FPJGB
Award Date
11/21/24
Potential Completion Date
12/13/24
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the supply of Mirena 52 mg Systems to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $1,776.00 firm fixed-price delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA). The $5,366.82 firm fixed-price delivery order is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains. DMS Pharmaceutical Group...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA). The $6,778.32 firm fixed-price delivery order is part of a $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to issue delivery orders for a wide range of pharmaceutical products, including branded and generic...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the provision of Mirena 52 mg systems. The $1,184 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) under the agency's Medical Supply Chain program. DMS Pharmaceutical Group is an established pharmaceutical wholesaler that supplies a wide range of medications, including branded and generic prescription drugs, over-the-counter products, biologics, and medical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of Mirena 52 mg systems to the U.S. Defense Logistics Agency (DLA). The $14,208 firm fixed-price delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of pharmaceutical items to support the medical supply needs of Department...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of MIRENA 52 MG SYSTEMS to the Defense Logistics Agency (DLA). The single-award, firm fixed-price delivery order is valued at $2,960.00 and has an ultimate completion date of September 26, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of pharmaceutical products and medical supplies to support the recurring medical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $2,960.00 for the supply of Mirena 52 mg systems. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is not associated with a set-aside designation. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA). The firm fixed-price delivery order, valued at $2,368.00, is placed under a larger indefinite delivery contract (IDC) with the DLA, named SPE2DB, which has a ceiling value of up to $499,999,999 and runs through December 31, 2025. This IDC allows the DLA to issue delivery orders for a...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of the MIRENA 52 MG SYSTEMS pharmaceutical product. The $6,249.24 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has an ultimate completion date of April 9, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
The Defense Logistics Agency (DLA) awarded a $5,207.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the procurement of Mirena 52 mg systems. This delivery order is part of a larger single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical...